Vascular calcification inhibitors in chronic kidney disease
Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry.
In vitro adsorption of direct oral anticoagulants from patient plasma samples
Nicotine from a Different Angle: Biological Effects from a Psychoneuroimmunological Perspective
Implementation of laboratory approach for persons with hemophilia requiring DOAC therapy.
Tavapraktikal põhinev tervishoiuteadus: lühiülevaade pragmaatilistest uuringutest
Laboratory Options for Assessing the Effects of Direct Oral Anticoagulants in Estonia
Higher versus lower mean arterial blood pressure after cardiac arrest and resuscitation (MAP-CARE): A protocol for a randomized clinical trial
Lipid management for primary and secondary stroke prevention consensus paper of the International Lipid Expert Panel (ILEP)
The European Program for Prevention (EPP) – Implementing Proven Preventing Measures Now!
Euroopa düslipideemia ravijuhend 2025: fookuses on kaasaegsed efektiivsed ravivõimalused
In-phase matrix profile: A novel method for the detection of major depressive disorder
Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)